유착 방지제 시장 보고서 : 제품별, 제제별, 용도별, 지역별(2025-2033년)

The global adhesion barriers market size reached USD 1,112.7 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,903.2 Million by 2033, exhibiting a growth rate (CAGR) of 5.84% during 2025-2033. The increasing applications of these film-based medical implants in cardiovascular, reconstructive, and urological surgeries are bolstering the market.

Adhesion Barriers Market Analysis:

• Major Market Drivers: The rising demand for postoperative procedures is one of the key factors catalyzing the market.
• Key Market Trends: The growing cases of sports-related injuries are acting as significant growth-inducing factors. Besides this, the increasing need for spray-type films that are more convenient and effective to use during laparoscopic systems is also contributing to the market.
• Competitive Landscape: Some of the prominent companies in the global market include Anika Therapeutics, Inc., Atrium Medical Corporation, Baxter International, Inc., Betatech Medical, C. R. Bard, Inc., FzioMed, Inc., LifeSciences Corporation, Medical Devices Business Services, Inc., MAST Biosurgery Inc., and Groupe Sanofi, among many others.
• Geographical Trends: The inflating healthcare expenditures of individuals are stimulating the market in North America.
• Challenges and Opportunities: The variability in efficacy is hampering the market. However, robust clinical evidence is expected to fuel the market in the coming years.

Adhesion Barriers Market Trends:

Growing Surgical Procedures

The increasing incidence of conditions requiring surgery, such as gynecological, cardiovascular, and orthopedic disorders, is catalyzing the market. Moreover, the inflating need for reducing the formation of scar tissue that can lead to pain, complications, and additional surgeries is also acting as another significant growth-inducing factor. For example, in April 2024, FzioMed, Inc. showcased its innovative Oxiplex adhesion barrier gel product portfolio designed to minimize the formation of post-surgical adhesions following laparoscopic and hysteroscopic surgery at Hysteroscopy, Assisted Reproductive Technology, and Ultrasound (HARTUS) congress in Rome, Italy. This is escalating the adhesion barriers market demand.

Increasing Technological Advancements

The rising adoption of biologics, along with the improvements in bioresorbable materials, are stimulating the market. They offer reduced inflammatory responses, better tissue compatibility, and easier application during surgical procedures. For instance, in February 2024, scientists at the Wyss Institute for Biologically Inspired Engineering at Harvard created a versatile and simple method to effectively bond layers made of the same or different types of hydrogels and other polymeric materials using a thin film of chitosan, which is expanding adhesion barriers market share.

Rising Novel Medical Treatment

The inflating healthcare expenditure capacities are strengthening the market. Apart from this, the increasing focus on providing better access to healthcare services is further providing a positive outlook to the market. For example, in May 2024, three projects from Radboud University Medical Center received funding from the BeNeFIT program, a collaboration between ZonMW and KCE. All three projects involve major clinical studies conducted in several hospitals across Belgium and the Netherlands. These studies focus on psychiatry, surgery, and intensive care.

Global Adhesion Barriers Industry Segmentation:

Breakup by Product:

• Synthetic
• Natural

Synthetic dominates the market

Synthetic adhesion barriers represent engineered materials that prevent post-surgical adhesions. One such example is REPEL-CV, a bioresorbable adhesion barrier designed for utilization in cardiovascular surgeries, which is increasing the adhesion barriers market outlook.

Breakup by Formulation:

• Film
• Liquid
• Gel

The film holds the majority of the global adhesion barriers market revenue

Film adhesion barriers are aimed at improving efficacy and patient outcomes. A significant launch is the GYNECARE INTERCEED absorbable adhesion barrier.

Breakup by Application:

• Gynecological Surgeries
• General/Abdominal Surgeries
• Cardiovascular Surgeries
• Orthopedic Surgeries
• Neurological Surgeries
• Reconstructive Surgeries
• Urological Surgeries
• Others

Gynecological surgeries dominate the adhesion barriers market statistics

The rising focus on preventing the formation of adhesions that can lead to complications is driving the segment's growth. PREVADH(R) absorbable adhesion barrier introduced by FzioMed is gaining extensive traction, as it is easy to handle.

Breakup by Region:

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

North America exhibits a clear dominance in the market

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

As per the adhesion barriers market overview, the widespread surgical procedures are acting as significant growth-inducing factors. For example, the REPEL-CV adhesion barrier by SyntheMed is specifically designed for cardiovascular surgeries.

Competitive Landscape:

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major adhesion barriers market companies have also been provided. Some of the key players in the market include:

• Anika Therapeutics, Inc.
• Atrium Medical Corporation
• Baxter International, Inc.
• Betatech Medical
• C. R. Bard, Inc.
• FzioMed, Inc.
• LifeSciences Corporation
• Medical Devices Business Services, Inc.
• MAST Biosurgery Inc.
• Groupe Sanofi

Key Questions Answered in This Report

• 1.What was the size of the global adhesion barriers market in 2024?
• 2.What is the expected growth rate of the global adhesion barriers market during 2025-2033?
• 3.What are the key factors driving the global adhesion barriers market?
• 4.What has been the impact of COVID-19 on the global adhesion barriers market?
• 5.What is the breakup of the global adhesion barriers market based on the product?
• 6.What is the breakup of the global adhesion barriers market based on the formulation?
• 7.What is the breakup of the global adhesion barriers market based on application?
• 8.What are the key regions in the global adhesion barriers market?
• 9.Who are the key players/companies in the global adhesion barriers market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Adhesion Barriers Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Synthetic
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Natural
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Formulation

• 7.1 Film
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Liquid
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Gel
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by Application

• 8.1 Gynecological Surgeries
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 General/Abdominal Surgeries
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Cardiovascular Surgeries
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Orthopedic Surgeries
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Neurological Surgeries
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast
• 8.6 Reconstructive Surgeries
  • 8.6.1 Market Trends
  • 8.6.2 Market Forecast
• 8.7 Urological Surgeries
  • 8.7.1 Market Trends
  • 8.7.2 Market Forecast
• 8.8 Others
  • 8.8.1 Market Trends
  • 8.8.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Indicators

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Anika Therapeutics Inc.
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
    • 14.3.1.4 SWOT Analysis
  • 14.3.2 Atrium Medical Corporation
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 Baxter International, Inc.
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 Betatech Medical
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 C. R. Bard, Inc.
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
  • 14.3.6 FzioMed Inc.
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
  • 14.3.7 LifeSciences Corporation
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
    • 14.3.7.4 SWOT Analysis
  • 14.3.8 Medical Devices Business Services, Inc.
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
    • 14.3.8.4 SWOT Analysis
  • 14.3.9 MAST Biosurgery Inc.
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
  • 14.3.10 Groupe Sanofi
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio